|
|
Found results for
 patents
1.
|
2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF TUMORS
| Application Number |
18687454 |
| Status |
Pending |
| Filing Date |
2022-06-01 |
| First Publication Date |
2024-11-14 |
| Owner |
- ISTITUTO PASTEUR ITALIA (Italy)
- IRCCS NEUROMED S.P.A. (Italy)
|
| Inventor |
Frati, Luigi
|
Abstract
1,2,3,4-tetrahydropyrimidine-5-carboxamide derivatives of formula (I) as aerobic glycolysis inhibitors and their use in the treatment of tumors.
1,2,3,4-tetrahydropyrimidine-5-carboxamide derivatives of formula (I) as aerobic glycolysis inhibitors and their use in the treatment of tumors.
IPC Classes ?
- C07D 239/557 - Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
- A61K 31/513 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61P 35/00 - Antineoplastic agents
|
2.
|
2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF TUMORS
| Application Number |
IB2022055143 |
| Publication Number |
2023/031683 |
| Status |
In Force |
| Filing Date |
2022-06-01 |
| Publication Date |
2023-03-09 |
| Owner |
- ISTITUTO PASTEUR ITALIA (Italy)
- IRCCS NEUROMED S.P.A. (Italy)
|
| Inventor |
Frati, Luigi
|
Abstract
1,2,3,4-tetrahydropyrimidine-5-carboxamide derivatives of formula (I) as aerobic glycolysis inhibitors and their use in the treatment of tumors.
IPC Classes ?
- C07D 239/557 - Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
- A61P 35/00 - Antineoplastic agents
- A61K 31/513 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
|
|
